No retraction, correction or concern found when last checked on Oct 26, 2026.
Possible Transmission of mcr-1 –Harboring Escherichia coli between Companion Animals and Human
Xue-Fei Zhang, Yohei Doi, Xi Huang and 6 more
Emerging Infectious Diseases · 2016 · Case report
Abstract
for 2014.This prevalence is increasing compared to that described in France in 2012 (14%).We found 35 A→G substitutions at position 2058 or 2059, two A2062T mutations and one A2059C mutation (Table) (1,9).Notably, in patients 15 and 33, who were infected with strains with macrolide resistance-associated mutations, M. genitalium infection was unsuccessfully treated with azithromycin, with treatment failures after azithromycin (1 g) and extended azithromycin (1.5 g for 5 d), but moxifloxacin treatment was effective.Patient 15 had been treated 1 year earlier with azithromycin (1 g) for nongonococcal urethritis.Among the 168 patients whose isolates were examined for the 23S rRNA, gyrA, and parC genes, strains from 2 patients (patients 3 and 6) had both macrolideand fluoroquinolone-associated mutations (1.2%; 95% CI 0.33%-4.24%).Both patients received azithromycin (1 g), and patient 6 received additional azithromycin (1.5 g) after failure of azithromycin (1 g).Patient 6 experienced azithromycin failure again after the extended regimen.M. genitalium multidrug resistance is described in France at a prevalence of 1.2%, lower than prevalence described in Australia (7.5%) (7) and Japan (30.8%) (10).In conclusion, M. genitalium fluoroquinolone resistance is emerging in France, with a prevalence of 6% in 2013-2014.Further, macrolide resistance also increased during this period, to a rate of 17.2%.Patients infected with M. genitalium strains containing both macrolide and fluoroquinolone resistance mutations associated with therapeutic failure raise concerns about untreatable M. genitalium infections.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 26, 2026. Paragraph numbers are ours, so an answer can point at one.
To the Editor: Plasmid-mediated, colistin-resistance mechanism gene mcr-1 was first identified in Escherichia coli isolates from food, food animals, and human patients in November 2015. Reports on detection of mcr-1 in Enterobacteriaceae from humans and food animals soon followed from ≈12 countries. Here we report detection of mcr-1 in colistin-resistant E. coli isolated from companion animals and the possible transmission of mcr-1–harboring E. coli between companion animals and a person.
Three mcr-1–harboring E. coli clinical isolates were identified from specimens of 3 patients admitted to a urology ward of a hospital in Guangzhou, China. E. coli isolate EC07 was identified in the urine of a 50-year-old male patient with glomerulonephritis in October 2015. Isolate EC08 was cultured from the urine of a 48-year-old male patient with prostatitis in December 2015. Isolate EC09 was identified in the blood of an 80-year-old male patient with bladder cancer 3 weeks after EC08 was identified.
Review of medical records identified the patient carrying E. coli isolate EC07 as a worker at a pet shop. In light of this finding, we collected a total of 53 fecal samples from 39 dogs and 14 cats in the pet shop where the man worked. We isolated and identified colonies consistent with E. coli from fecal samples on MacConkey agar plates (Thermo Fisher, Beijing, China) and API 20E system (bioMérieux, Durham, NC, USA). We prepared crude DNA samples of isolates for PCR testing by boiling cells in water. Among them, 6 were positive for mcr-1 by PCR and sequencing (4 from dogs and 2 from cats). All 6 isolates were resistant to colistin, polymyxin B, cephalosporin, gentamicin, and ciprofloxacin by using the agar dilution method, in accordance with the European Committee on Antimicrobial Susceptibility Testing (http://www.eucast.org) for colistin and polymyxin B and Clinical and Laboratory Standards Institute guidelines (http://www.clsi.org) for the other antimicrobial drugs. We identified various resistance genes accounting for the multidrug resistance in these 9 mcr-1–positive isolates (Table). We noted that E. coli isolate EC09 was also resistant to carbapenems and positive for blaIMP-4. We observed co-production of mcr-1 and IMP-type metallo-β-lactamase in E. coli.
We subjected all isolates to multilocus sequence typing, in accordance with the protocol described at http://mlst.warwick.ac.uk/mlst/dbs/Ecoli, and pulsed-field gel electrophoresis as described previously. We identified 5 mcr-1–positive isolates from 4 dogs (PET02–04 and PET06) and isolate EC07 as sequence type (ST) 354. Isolates PET01 and PET05, identified from cats, belonged to ST93 and a new ST strain, respectively. Isolates EC08 and EC09, from the patients who shared the same hospital room with the pet shop worker, were ST156 (Table). Results of pulsed-field gel electrophoresis were consistent with multilocus sequence typing results and showed that isolates consisted of 5 types (types I to V; Technical Appendix). Isolate EC07 was clonally related to 4 E. coli strains from dogs, according criteria described by Tenover et al., suggesting possible transmission of mcr-1–harboring E. coli between dogs and the patient. Colistin resistance was successfully transferred to E. coli C600 through conjugation in all isolates, suggesting that mcr-1 was located on transferable plasmids.
These findings suggest that mcr-1–producing E. coli can colonize companion animals and be transferred between companion animals and humans. The findings also suggest that, in addition to food animals and humans, companion animals can serve as a reservoir of colistin-resistant E. coli, adding another layer of complexity to the rapidly evolving epidemiology of plasmid-mediated colistin resistance in the community.
References 10
- 1.
Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16:161–8.
Not in our library10.1016/s1473-3099(15)00424-7
- 2.
Nordmann P, Lienhard R, Kieffer N, Clerc O, Poirel L. Plasmid-mediated colistin-resistant Escherichia coli in bacteremia in Switzerland. Clin Infect Dis. 2016 Mar 1:ciw124.
Not in our library10.1093/cid/ciw124
- 3.
Falgenhauer L, Waezsada SE, Yao Y, Imirzalioglu C, Käsbohrer A, Roesler U, Colistin resistance gene mcr-1 in extended-spectrum β-lactamase–producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect Dis. 2016;16:282–3.
Not in our library10.1016/s1473-3099(16)00009-8
- 4.
Tse H, Yuen KY. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016;16:145–6.
Not in our library10.1016/s1473-3099(15)00532-0
- 5.
Malhotra-Kumar S, Xavier BB, Das AJ, Lammens C, Butaye P, Goossens H. Colistin resistance gene mcr-1 harboured on a multidrug resistant plasmid. Lancet Infect Dis. 2016;16:283–4.
Not in our library10.1016/s1473-3099(16)00012-8
- 6.
Tian GB, Huang YM, Fang ZL, Qing Y, Zhang XF, Huang X. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15–like β-lactamases identified in an Escherichia coli clinical isolate. J Antimicrob Chemother. 2014;69:2081–5.
Not in our library10.1093/jac/dku126
- 7.
Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–54.
Not in our library10.1128/aac.00774-09
- 8.
Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol. 2006;60:1136–51.
Not in our library10.1111/j.1365-2958.2006.05172.x
- 9.
Tian GB, Wang HN, Zhang AY, Zhang Y, Fan WQ, Xu CW, Detection of clinically important β-lactamases in commensal Escherichia coli of human and swine origin in western China. J Med Microbiol. 2012;61:233–8.
Not in our library10.1099/jmm.0.036806-0
- 10.
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.
Not in our library10.1128/jcm.33.9.2233-2239.1995
Cited by papers we hold 10
- Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria · 2021No notice
- Prevalence and risk analysis of mobile colistin resistance and extended-spectrum β-lactamase genes carriage in pet dogs and their owners: a population based cross-sectional study · 2021Not checked
- Antimicrobial prescriptions in cats in Switzerland before and after the introduction of an online antimicrobial stewardship tool · 2020Not checked
- Co-occurrence of mcr-1 mediated colistin resistance and β-lactamase-encoding genes in multidrug-resistant Escherichia coli from broiler chickens with colibacillosis in Tunisia · 2020Not checked
- Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges · 2020No notice
- Overview of Evidence of Antimicrobial Use and Antimicrobial Resistance in the Food Chain · 2020No notice
- The global distribution and spread of the mobilized colistin resistance gene mcr-1 · 2018No notice
- 野生动物(野鸟)对全球耐药基因传播的影响 · 2017No notice
- Dissemination and Mechanism for the MCR-1 Colistin Resistance · 2016No notice
- Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives · 2016No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.